Home
About Us
Products
Services
Partnerships
News
News
2010
2009
2008
News
Meet Us
September 2, 2010
ImaginAb’s co-founder, Dr. Anna Wu, invited to speak by the Korean Society of Molecular Imaging at the WMIC pre-conference satellite meeting in Seoul, Korea
September 1, 2010
ImaginAb will be attending the AntibOZ International Antibody Conference
August 20, 2010
ImaginAb will be attending the World Molecular Imaging Congress in Kyoto, Japan
June 3, 2010
ImaginAb Inc. and A*STAR Jointly Develop Recombinant Antibody Fragment for Diagnostic Imaging
May 17, 2010
ImaginAb and GlaxoSmithKline establish collaboration
March 31, 2010
ImaginAb successfully completes pre-clinical work for huJ591/Prostate-Specific Membrane Antigen (PSMA) NCI SBIR contract
October 1, 2009
ImaginAb and BZL Biologics, LLC conclude licensing agreement for imaging rights to huJ591/Prostate-Specific Membrane Antigen
October 1, 2009
ImaginAb is awarded NCI SBIR contract in support of its work with huJ591/Prostate-Specific Membrane Antigen (PSMA)
September 24, 2009
ImaginAb announces “Imaximab” Line of Pre-Clinical Imaging Agents for use with PET and SPECT small animal imaging
September 23, 2009
ImaginAb exhibits its new line of targeted antibodies for preclinical imaging at the World Molecular Imaging Conference